The fumaric acid ester BG-12: a new option in MS therapy.
about
Chemical tuning enhances both potency toward nrf2 and in vitro therapeutic index of triterpenoidsNrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitisThe clinical potential of influencing Nrf2 signaling in degenerative and immunological disordersDimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK PathwayDimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages.New melatonin-cinnamate hybrids as multi-target drugs for neurodegenerative diseases: Nrf2-induction, antioxidant effect and neuroprotection.Dimethylfumarate induces apoptosis in human mast cells.
P2860
Q28391638-133438E9-4A00-4D26-B301-39700A4C3B5FQ28394597-630652AF-BE64-42CD-BE0E-2C76E68D8759Q28395641-93E78E0D-5435-47D0-9462-28677C9EDC85Q35814106-3BEDF346-2F73-483F-B486-D56D26AD3B82Q36867383-7902E187-74D7-4D96-8B15-AB7BBBBB8AE8Q38950400-AB8A115D-27B3-41FC-950E-BEB6E93BF6B1Q39083128-B9ED875E-76DC-46C9-A262-B39AFAE39E21
P2860
The fumaric acid ester BG-12: a new option in MS therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The fumaric acid ester BG-12: a new option in MS therapy.
@en
type
label
The fumaric acid ester BG-12: a new option in MS therapy.
@en
prefLabel
The fumaric acid ester BG-12: a new option in MS therapy.
@en
P2093
P2860
P1476
The fumaric acid ester BG-12: a new option in MS therapy.
@en
P2093
De-Hyung Lee
Martin Stangel
Ralf Andreas Linker
P2860
P304
P356
10.1586/14737175.2013.814958
P577
2013-08-14T00:00:00Z